Review of Transient Receptor Potential Canonical (TRPC5) Channel Modulators and Diseases

Swagat Sharma, Corey R Hopkins

Research output: Contribution to journalReview article

Abstract

Transient receptor potential canonical (TRPC) channels are highly homologous, nonselective cation channels that form many homo- and heterotetrameric channels. These channels are highly abundant in the brain and kidney and have been implicated in numerous diseases, such as depression, addiction, and chronic kidney disease, among others. Historically, there have been very few selective modulators of the TRPC family in order to fully understand their role in disease despite their physiological significance. However, that has changed recently and there has been a significant increase in interest in this family of channels which has led to the emergence of selective tool compounds, and even preclinical drug candidates, over the past few years. This review will cover these new advancements in the discovery of TRPC modulators and the emergence of newly reported structural information which will undoubtedly lead to even greater advancements.

Original languageEnglish (US)
Pages (from-to)7589-7602
Number of pages14
JournalJournal of Medicinal Chemistry
Volume62
Issue number17
DOIs
StatePublished - Sep 12 2019

Fingerprint

Transient Receptor Potential Channels
Chronic Renal Insufficiency
Cations
Kidney
Brain
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery

Cite this

Review of Transient Receptor Potential Canonical (TRPC5) Channel Modulators and Diseases. / Sharma, Swagat; Hopkins, Corey R.

In: Journal of Medicinal Chemistry, Vol. 62, No. 17, 12.09.2019, p. 7589-7602.

Research output: Contribution to journalReview article

@article{d0a65f1ae2e4450fb59a4e6bbad4553b,
title = "Review of Transient Receptor Potential Canonical (TRPC5) Channel Modulators and Diseases",
abstract = "Transient receptor potential canonical (TRPC) channels are highly homologous, nonselective cation channels that form many homo- and heterotetrameric channels. These channels are highly abundant in the brain and kidney and have been implicated in numerous diseases, such as depression, addiction, and chronic kidney disease, among others. Historically, there have been very few selective modulators of the TRPC family in order to fully understand their role in disease despite their physiological significance. However, that has changed recently and there has been a significant increase in interest in this family of channels which has led to the emergence of selective tool compounds, and even preclinical drug candidates, over the past few years. This review will cover these new advancements in the discovery of TRPC modulators and the emergence of newly reported structural information which will undoubtedly lead to even greater advancements.",
author = "Swagat Sharma and Hopkins, {Corey R}",
year = "2019",
month = "9",
day = "12",
doi = "10.1021/acs.jmedchem.8b01954",
language = "English (US)",
volume = "62",
pages = "7589--7602",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "17",

}

TY - JOUR

T1 - Review of Transient Receptor Potential Canonical (TRPC5) Channel Modulators and Diseases

AU - Sharma, Swagat

AU - Hopkins, Corey R

PY - 2019/9/12

Y1 - 2019/9/12

N2 - Transient receptor potential canonical (TRPC) channels are highly homologous, nonselective cation channels that form many homo- and heterotetrameric channels. These channels are highly abundant in the brain and kidney and have been implicated in numerous diseases, such as depression, addiction, and chronic kidney disease, among others. Historically, there have been very few selective modulators of the TRPC family in order to fully understand their role in disease despite their physiological significance. However, that has changed recently and there has been a significant increase in interest in this family of channels which has led to the emergence of selective tool compounds, and even preclinical drug candidates, over the past few years. This review will cover these new advancements in the discovery of TRPC modulators and the emergence of newly reported structural information which will undoubtedly lead to even greater advancements.

AB - Transient receptor potential canonical (TRPC) channels are highly homologous, nonselective cation channels that form many homo- and heterotetrameric channels. These channels are highly abundant in the brain and kidney and have been implicated in numerous diseases, such as depression, addiction, and chronic kidney disease, among others. Historically, there have been very few selective modulators of the TRPC family in order to fully understand their role in disease despite their physiological significance. However, that has changed recently and there has been a significant increase in interest in this family of channels which has led to the emergence of selective tool compounds, and even preclinical drug candidates, over the past few years. This review will cover these new advancements in the discovery of TRPC modulators and the emergence of newly reported structural information which will undoubtedly lead to even greater advancements.

UR - http://www.scopus.com/inward/record.url?scp=85064970356&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064970356&partnerID=8YFLogxK

U2 - 10.1021/acs.jmedchem.8b01954

DO - 10.1021/acs.jmedchem.8b01954

M3 - Review article

VL - 62

SP - 7589

EP - 7602

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 17

ER -